期刊
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
卷 91, 期 11, 页码 4645-4649出版社
ENDOCRINE SOC
DOI: 10.1210/jc.2006-0844
关键词
-
资金
- Medical Research Council [MC_U106179472] Funding Source: Medline
- Wellcome Trust Funding Source: Medline
- Medical Research Council [MC_U106179472] Funding Source: researchfish
- MRC [MC_U106179472] Funding Source: UKRI
Introduction: Insulin resistance ( IR) develops as early as age 1 to 3 yr in small for gestational age ( SGA) infants who show rapid catch- up postnatal weight gain. In contrast, greater insulin secretion is related to infancy height gains. We hypothesized that IGF-I levels could be differentially related to gains in length and weight and also differentially related to IR and insulin secretion. Methods: In a prospective study of 50 SGA ( birth weight < 5th percentile) and 14 normal birth weight [ appropriate for gestational age ( AGA)] newborns, we measured serum IGF-I levels at birth, 1 yr, and 3 yr. IR ( by homeostasis model assessment) and insulin secretion ( by short iv glucose tolerance test) were also measured at 1 yr and 3 yr. Results: SGA infants had similar mean length and weight at 3 yr compared with AGA infants. SGA infants had lower IGF- I levels at birth ( P < 0.0001), but conversely they had higher IGF- I levels at 3 yr ( P < 0.003) than AGA infants. Within the SGA group, at 1 yr IGF- I was associated with length gain from birth and insulin secretion ( P < 0.0001); in contrast at 3 yr IGF- I was positively related to weight, body mass index, and IR. Conclusions: IGF- I levels increased rapidly from birth in SGA, but not AGA children. During the key first- year growth period, IGF- I levels were related to beta- cell function and longitudinal growth. In contrast, by 3 yr, when catch- up growth was completed, IGF- I levels were related to body mass index and IR, and these higher IGF- I levels in SGA infants might indicate the presence of relative IGF-I resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据